Dr. Yingda Xie received her M.D. from the University of Texas in San Antonio, completed Internal Medicine residency training at Oregon Health Sciences University, and clinical and research fellowship in Infectious Diseases at the National Institutes of Health. Her interest in tuberculosis grew after a memorable clinical encounter during residency highlighted the outdated diagnostics and therapies used to combat the morbid, globally-prevalent disease. Dr Xie joined Rutgers NJMS in 2019 after receiving a NIAID K22 and Gates Foundation pilot award. Her research group in the Center of Emerging Pathogens, Rutgers NJMS works on developing and optimizing clinical tools to study, diagnose, and treat tuberculosis.